MedPath

Comparison Between Natural Sleep Endoscopy and Drug-induced Sleep Endoscopy in Patients With Obstructive Sleep Apnea

Not Applicable
Conditions
Dyssomnia
Physiological Effects of Drugs
Sleep Apnea, Obstructive
Respiratory Tract Disease
Hypnotics and Sedatives
Central Nervous System Depressants
Respiration Disorder
Sleep Wake Disorders
Midazolam
Sleep Apnea
Interventions
Device: Natural sleep endoscopy
Device: Drug-induced sleep endoscopy
Registration Number
NCT04729478
Lead Sponsor
ethisch.comite@uza.be
Brief Summary

Drug-induced sleep endoscopy (DISE) is the most used technique for identifying the obstruction site associated with obstructive sleep apnea (OSA). This is due to the fact that it allows many patients to be examined in a daytime setting. This procedure uses sedative drugs to mimic natural sleep. However, associations with the site of upper airway (UA) collapse during natural sleep remain unclear.

The aim of this explorative study is to identify UA collapse in patients with OSA using endoscopic techniques as well as flow shape characteristics and sound analyses during natural and drug-induced sleep. Furthermore, we want to optimize the measurement set-up of natural sleep endoscopy (NSE).

Detailed Description

Patients with moderate to severe OSA requiring DISE will be recruited for this prospective study at the outpatient clinic. Patients will undergo a NSE at the sleep lab at night, and a DISE at the operating theatre within three months. Both the NSE and DISE set-up will include gold-standard flow measurements, acoustic analysis and esophageal pressure measurements.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Diagnosis of OSA with a baseline AHI ≥ 15 per hour based on full polysomnography
  • Body mass index (BMI) ≤ 35 kg/m²
  • Capability of giving informed consent and willingness to undergo NSE
Exclusion Criteria
  • Central sleep apnea (defined as CAHI ≥ 30% of total AHI)
  • Inability to sleep in a supine position due to a medical condition
  • Inability of the patient to understand and/or comply to the study procedures
  • Neuromuscular disorders or craniofacial anomalies affecting the UA
  • Sedative medication use (opioids and muscle relaxants)
  • Active psychiatric disorders (psychotic illness, major depression, anxiety attacks, excessive alcohol or drug use)
  • Severe or decompensated cardiac or respiratory diseases
  • Medical history of known causes of tiredness by day or severe sleep disruption (insomnia, PLMS, narcolepsy)
  • Contra-indications for DISE: i.e. fitness for general anesthesia (ASA>3), allergy to sedative agent(s) and an expected extremely difficult airway
  • Pregnancy or willing to become pregnant

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Natural sleepNatural sleep endoscopyNatural sleep endoscopy (NSE) OSA patients will be endoscopically evaluated during natural sleep. During NSE additional physiological measurements (flow shape analysis, acoustic analysis of snoring sounds and esophageal pressure measurements) will be carried out.
Drug-induced sleepDrug-induced sleep endoscopyDrug-induced sleep endoscopy (DISE) OSA patients will be endoscopically evaluated during drug-induced sleep. During DISE additional physiological measurements (flow shape analysis, acoustic analysis of snoring sounds and esophageal pressure measurements) will be carried out.
Primary Outcome Measures
NameTimeMethod
Endoscopic Classification SystemImmediately, during the procedure

Comparison of the frequencies of the site, gradation and pattern of upper airway collapse between natural and drug-induced sleep endoscopy.

Secondary Outcome Measures
NameTimeMethod
Acoustic analysisImmediately, during the procedure

Acoustic analyses measured during both natural and drug-induced sleep endoscopy

Flow shape analysisImmediately, during the procedure

Several parameters extracted from the flow signal, including negative effort dependence (NED), peak inspiratory flow, etc. measured during both natural and drug-induced sleep endoscopy.

Trial Locations

Locations (1)

Antwerp University Hospital

🇧🇪

Edegem, Antwerp, Belgium

© Copyright 2025. All Rights Reserved by MedPath